Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus

Journal of Perinatology

Volumn 31, Issue 7, 2011, Pages 465-470

  Rao, R ^a   Bryowsky, K ^b   Mao, J ^c   Bunton, D ^d   McPherson, C ^d   Mathur, A ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b SSM St Clare Health Center   (United States)

^c Patient Oriented Research Unit   (United States)

^d ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

ibuprofen; patent ductus arteriosus; preterm; spontaneous intestinal perforation

Indexed keywords

HYDROCORTISONE; IBUPROFEN LYSINE; IONOTROPIC RECEPTOR ANTAGONIST;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTESTINE PERFORATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RETROSPECTIVE STUDY; RISK FACTOR;

COHORT STUDIES; CONFIDENCE INTERVALS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DUCTUS ARTERIOSUS, PATENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; IBUPROFEN; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INTESTINAL PERFORATION; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 79959845448     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.199     Document Type: Article

References (34)

1. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003; 88(6): F464-F466. (Pubitemid 37449418)
2. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010; CD000174.
3. Ment LR, Vohr BR, Makuch RW, Westerveld M, Katz KH, Schneider KC et al. Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. J Pediatr 2004; 145(6): 832-834. (Pubitemid 39586624)
4. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007; 119(6): 1165-1174.
5. Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92(6): F498-F502.
6. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30(4): 241-252.
7. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343(10): 674-681.
8. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC. Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008; 93(2): F94-F99.
9. Aranda JV, Thomas R. Systematic review: intravenous ibuprofen in preterm newborns. Semin Perinatol 2006; 30(3): 114-120. (Pubitemid 43928131)
10. Alpan G, Eyal F, Vinograd I, Udassin R, Amir G, Mogle P et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 1985; 106(2): 277-281. (Pubitemid 15130083)
11. Knight DB. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001; 6(1): 63-73.
12. Nagaraj HS, Sandhu AS, Cook LN, Buchino JJ, Groff DB. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediatr Surg 1981; 16(6): 1003-1007. (Pubitemid 12212890)
13. Aschner JL, Deluga KS, Metlay LA, Emmens RW, Hendricks-Munoz KD. Spontaneous focal gastrointestinal perforation in very low birth weight infants. J Pediatr 1988; 113(2): 364-367.
14. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations. J Perinatol 2006; 26(3): 185-188.
15. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006; 26(2): 93-99.
16. Tatli MM, Kumral A, Duman N, Demir K, Gurcu O, Ozkan H. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants. Acta Paediatr 2004; 93(7): 999-1001.
17. Gordon PV, Swanson JR, Attridge JT, Clark R. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria? J Perinatol 2007; 27(11): 661-671.
18. Gordon PV. Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr Res 2009; 65(2): 138-144.
19. Gordon PV, Attridge JT. Understanding clinical literature relevant to spontaneous intestinal perforations. Am J Perinatol 2009; 26(4): 309-316.
20. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114(6): 1649-1657. (Pubitemid 41754933)
21. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004; 364(9449): 1939-1944. (Pubitemid 39574596)
22. Katakam LI, Cotten CM, Goldberg RN, Dang CN, Smith PB. Safety and effectiveness of indomethacin versus ibuprofen for treatment of patent ductus arteriosus. Am J Perinatol 2010; 27(5): 425-429.
23. Salama H AA, Alrifai H, Shaddad A, Samawal L, Habboub L, Masoud A. The use of oral ibuprofen to close the patent ductus arteriosus in the premature infants. J Neonat-Perinat Med 2008; 1(3): 153-158.
24. O'Donovan DJ, Baetiong A, Adams K, Chen A, Smith EO, Adams JM et al. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol 2003; 23(4): 286-290. (Pubitemid 36764116)
25. Shorter NA, Liu JY, Mooney DP, Harmon BJ. Indomethacin-associated bowel perforations: a study of possible risk factors. J Pediatr Surg 1999; 34(3): 442-444. (Pubitemid 29146505)
26. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010; (4): CD003481.
27. Bloom BT. Attridge et al. present an analysis of a complex data set, which offers important confirmation of the differences between the clinical presentation of spontaneous intestinal perforations (SIP) and surgical necrotizing enterocolitis (NEC). J Perinatol 2006; 26(6): 384-386; author reply.
28. Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 2008; 65(5): 629-636.
29. Novack CM, Waffarn F, Sills JH, Pousti TJ, Warden MJ, Cunningham MD. Focal intestinal perforation in the extremely-low-birth-weight infant. J Perinatol 1994; 14(6): 450-453.
30. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344(2): 95-101.
31. Blakely ML, Lally KP, McDonald S, Brown RL, Barnhart DC, Ricketts RR et al. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Ann Surg 2005; 241(6): 984-989; discussion 989-994.
32. Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 1996; 224(3): 350-355;discussion 355-357.
33. Attridge JT, Herman AC, Gurka MJ, Griffin MP, McGahren ED, Gordon PV. Discharge outcomes of extremely low birth weight infants with spontaneous intestinal perforations. J Perinatol 2006; 26(1): 49-54. (Pubitemid 43135255)
34. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117(4): 1113-1121. (Pubitemid 46071502)